Please login to the form below

Not currently logged in
Email:
Password:

Owlstone Medical bolsters management team

Chris Hodkinson, Dr Marc van der Schee and Hamilton Scanlon join

Owlstone Medical Chris HodkinsonCambridge, UK-based diagnostics firm Owlstone Medical has added three business development, clinical research and manufacturing executives to its senior management team.

Chris Hodkinson (pictured) becomes vice president of business development, taking on responsibility for the company's cancer products business operations.

He joins Owlstone Medical from Abcodia, a specialist company focused on developing biomarkers for cancer screening that he co-founded, having most recently served as director and chief operating officer.

Meanwhile Dr Marc van der Schee has been appointed as lead clinical research scientist for the diagnostics firm, with a remit to design and oversee all clinical trials and product development.

He brings 10 years of biomarker research experience to Owlstone Medical, including medical, epidemiological, chemical analytical and data-analysis for which he was awarded a Marie Curie fellowship.

Lastly, Hamilton Scanlon joins the firm as vice president of manufacturing and brings over 30 years of industry experience across China, Italy and the UK to the role.

Scanlon will be tasked with manufacturing the scale-up of Owlstone Medical's clinical research and development tools used in biomarker discovery.

Billy Boyle, co-founder and chief executive officer of Owlstone Medical, said: “Owlstone Medical was created very specifically to advance our breathalyzer for very early stage diagnosis of disease when it can be treated more effectively for better patient outcomes.

“We are excited to see the company expanding so soon after being spun-out, and are confident that Chris, Marc and Hamilton will be great assets to the team.”

31st August 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics